Browse > Article

Risk Factors for Primary Multidrug Resistant Tuberculosis  

Min, Jinhong (National Masan Hospital)
Park, Keeho (Korea Center for Disease Control and Prevention)
Whang, Suhee (National Masan Hospital)
Kim, Jinhee (National Masan Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.59, no.6, 2005 , pp. 600-605 More about this Journal
Abstract
Background : Primary multidrug-resistant tuberculosis is defined as Mycobacterium tuberculosis isolates that are resistant to at least isoniazid and rifampin in never-been-treated tuberculosis patients, and this malady is caused by the transmission of a resistant strain from one patient, who is infected with a resistant Mycobacterium tuberculosis strain, to another patient. The prevalence of primary multidrug-resistant tuberculosis could be a good indicator of the performance of tuberculosis control programs in recent years. We conducted a case-control study to identify the risk factors for primary multidrug-resistant tuberculosis. Methods : From January 1, 2001 to, June 30, 2003, by conducting prospective laboratory-based surveillance, we identified 29 hospitalized patients with P-MDRTB and these patients constituted a case group in this study. The controls were represented by all the patients with culture-confirmed drug susceptible tuberculosis who were admitted to National Masan Hospital during the same study period. The odds ratios for the patients with primary multidrug-resistant tuberculosis, as compared with those of the patients with drug susceptible tuberculosis, were calculated for each categorical variable with 95% confidence intervals. Results : Multivariate logistic regression showed that the presence of diabetes mellitus (odds ratio 2.68; 95% confidence interval, 1.05-6.86) was independently associated with having primary multidrug-resistant tuberculosis. Conclusion : This study has shown that diabetes mellitus might be one of the risk factors for primary multidrug-resistant tuberculosis.
Keywords
Drug resistance; Mycobacterium tuberculosis; Risk factor;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baez J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283:2537-45   DOI   ScienceOn
2 Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995;76:529-33   DOI   ScienceOn
3 Kessler I. Mortality experience of diabetic patients: a twenty-six year follow-up study. Am J Med 1971; 51:715
4 Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270:65-68   DOI   ScienceOn
5 Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987-1997. Chest 2001; 120:1514-1519
6 World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 2: Prevalence and trends. WHO/CDS/TB/2000.278; 2000; 220
7 Matthay M. The lungs and endocrine disease. In Murray J, Nadel J (eds). Textbook of respiratory medicine. Philadelphia: WB Saunders, 1988: p1921
8 Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, et al. Global trends in resistance to antituberculosis drugs. N Engl J Med 2001; 344:1294-1303   DOI   PUBMED   ScienceOn
9 Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Mortality and causes of death in Type 2 diabetic patients: a long-term follow-up study in Osaka District, Japan. Diabetes Res Clin Prac 1989; 7:33
10 Reider HL, Cauthen GM, Comstock GW, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev. Epidemio Rev 1989;11:79-98
11 CDC. Primary multidrug-resistant tuberculosis-Ivanovo Oblast, Russia, 1999. MMWR 1999; 48:661-664
12 Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Infect Dis Clin North Am 1995; 9:65-96
13 Sentochnik D, Eliopoulos G. Infection and diabetes. In Kahn C, Weir G (eds). Joslin's diabetes mellitus, 13th ed. Philadelphia: Lea & Febiger, 1994: p867
14 Rusch-Gerdes S. Epidemiology of resistant tuberculosis in Europe. Infection 1999; 27 (suppl):S17-18   DOI